查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1534099

狐臭治疗的全球市场

Bromhidrosis Disease Treatment
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 250 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年全球狐臭治疗市场预计将达到12亿美元

2023年全球腋臭治疗市场估计为7.563亿美元，预计到2030年将达到12亿美元，2023-2030年分析期间复合年增长率为6.8%。大汗腺体臭治疗是本报告分析的细分市场之一，预计复合年增长率为 7.7%，到分析期结束时将达到 7.428 亿美元。在分析期间，小汗腺体臭治疗领域的复合年增长率估计为 5.4%。

美国市场预估价值2.06亿美元，中国预期复合年增长率11.1%

预计 2023 年美国狐臭治疗市场规模将达 2.06 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达2.646亿美元，2023年至2030年复合年增长率为11.1%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.9% 和 6.8%。在欧洲，德国的复合年增长率预计为 4.3%。

全球腋臭治疗市场－主要驱动因素和趋势总结

臭汗症，俗称体臭病，是一种以汗液细菌分解引起的过度且令人不快的体臭为特征的疾病。这种疾病主要影响腋窝和鼠蹊部等区域的顶泌汗腺。狐臭分为大汗腺汗腺病和小汗腺汗腺病。顶泌汗臭汗症与细菌分解汗液有关，而小汗腺臭汗症则与皮肤表面小汗腺分解汗液有关。臭汗症的治疗旨在减少汗水分泌、最大限度地减少细菌活动并有效控制气味。

溴多汗症的治疗已经取得了显着的进展，结合了医学和非医学方法。传统治疗方法包括使用含有氯化铝的局部止汗剂和除臭剂来减少汗水和掩盖气味。在更严重的情况下，医生可能会开抗生素来对抗细菌感染，或建议进行抗菌清洗以减少皮肤上的细菌负荷。此外，肉毒桿菌（Botox）注射等治疗方法越来越受欢迎，因为它们可以暂时阻断负责出汗的神经讯号。汗腺切除和切除术等手术选择为严重病例提供了更永久的解决方案。最近的进展还包括雷射疗法和微波热解，它们瞄准并破坏过度活跃的汗腺，从而长期缓解症状。

溴多汗症治疗市场的成长是由多种因素所推动的。首先，与体臭相关的认识的提高和社会耻辱正在促使更多的人寻求治疗，从而增加了对有效治疗方法的需求。其次，皮肤病学研究和技术的进步扩大了治疗选择，使治疗变得更容易和更有效。此外，可支配收入的增加和医疗保健基础设施的改善，特别是在发展中地区，促进了非侵入性和手术治疗的获得。电子商务和远端医疗平台的发展也使患者更容易获得专业治疗和咨询。此外，人口老化更容易出现与出汗相关的问题，这增加了对先进狐臭治疗的需求。最后，製药和化妆品公司为传播其产品的知名度和益处而进行的策略行销努力在推动市场扩张方面发挥着重要作用。

受访企业范例（共86家）

  • Avanor Healthcare Ltd
  • Cantabria Labs
  • Clutch, Inc.（DBA Carpe）
  • Ducray Dermatological Laboratories
  • Galderma SA
  • Ipsen Pharma
  • Medytox, Inc.
  • Merz Pharma
  • No More Sweat
  • Pampered Skin Care, LLC
  • Salve Pharmaceuticals Pvt. Ltd.
  • Seaford Pharmaceuticals Inc.
  • The Polar Company BV

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP26610

Global Bromhidrosis Disease Treatment Market to Reach US$1.2 Billion by 2030

The global market for Bromhidrosis Disease Treatment estimated at US$756.3 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Apocrine Body Odor Treatment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$742.8 Million by the end of the analysis period. Growth in the Eccrine Body Odor Treatment segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$206.0 Million While China is Forecast to Grow at 11.1% CAGR

The Bromhidrosis Disease Treatment market in the U.S. is estimated at US$206.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$264.6 Million by the year 2030 trailing a CAGR of 11.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Bromhidrosis Disease Treatment Market - Key Drivers and Trends Summarized

Bromhidrosis, commonly known as body odor, is a medical condition characterized by excessive and offensive body odor caused by bacterial decomposition of sweat. This condition primarily affects the apocrine sweat glands found in areas such as the armpits and groin. Bromhidrosis can be classified into two types: apocrine and eccrine. Apocrine bromhidrosis is associated with the bacterial breakdown of sweat, while eccrine bromhidrosis is linked to the decomposition of sweat from the eccrine glands on the skin's surface. Treatment for bromhidrosis aims to reduce sweat production, minimize bacterial activity, and manage the odor effectively.

The treatment landscape for bromhidrosis has evolved considerably, incorporating both medical and non-medical approaches. Traditional treatments include the use of topical antiperspirants and deodorants that contain aluminum chloride to reduce sweat and mask the odor. For more severe cases, physicians may prescribe antibiotics to address bacterial infections or recommend antiseptic washes to reduce bacterial load on the skin. Additionally, treatments such as botulinum toxin (Botox) injections have gained popularity for their ability to temporarily block nerve signals responsible for sweating. Surgical options, including the removal of sweat glands and sympathectomy, offer more permanent solutions for severe cases. Recent advancements also include laser treatments and microwave thermolysis, which target and destroy overactive sweat glands, providing long-term relief from symptoms.

The growth in the bromhidrosis treatment market is driven by several factors. Firstly, the increasing awareness and social stigma associated with body odor have led more individuals to seek medical treatment, boosting demand for effective therapies. Secondly, advancements in dermatological research and technology have expanded treatment options, making them more accessible and efficient. Additionally, the rise in disposable incomes and improved healthcare infrastructure, particularly in developing regions, has facilitated greater access to both non-invasive and surgical treatments. The growth of e-commerce and telemedicine platforms has also made it easier for patients to access specialized treatments and consultations. Furthermore, the aging population, which is more prone to sweat-related issues, has increased the need for advanced bromhidrosis treatments. Lastly, strategic marketing efforts by pharmaceutical and cosmetic companies to promote awareness and the benefits of their products have played a crucial role in driving market expansion.

Select Competitors (Total 86 Featured) -

  • Avanor Healthcare Ltd
  • Cantabria Labs
  • Clutch, Inc. (DBA Carpe)
  • Ducray Dermatological Laboratories
  • Galderma SA
  • Ipsen Pharma
  • Medytox, Inc.
  • Merz Pharma
  • No More Sweat
  • Pampered Skin Care, LLC
  • Salve Pharmaceuticals Pvt. Ltd.
  • Seaford Pharmaceuticals Inc.
  • The Polar Company B.V.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Bromhidrosis Disease Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Bromhidrosis and Its Impact on Quality of Life Drives Demand for Treatments
    • Advancements in Dermatological Treatments Enhance Efficacy and Patient Satisfaction
    • Growing Acceptance of Cosmetic and Aesthetic Procedures Expands Market Opportunities
    • Expansion of Dermatology Clinics and Specialty Centers Increases Market Reach
    • Development of Minimally Invasive and Non-Invasive Treatment Options Attracts Patients
    • Increasing Use of Laser and Radiofrequency Therapies in Bromhidrosis Treatment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bromhidrosis Disease Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bromhidrosis Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Apocrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Apocrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Apocrine Body Odor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Eccrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Eccrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Eccrine Body Odor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • JAPAN
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • CHINA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • EUROPE
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Bromhidrosis Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • FRANCE
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • GERMANY
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Bromhidrosis Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • INDIA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Bromhidrosis Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Bromhidrosis Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • AFRICA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030

IV. COMPETITION